ニュース

Satsuma, a unit of a Japanese drugmaker with U.S. headquarters in Durham, said its treatment, called Atzumi, received its new ...
Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate NC had helped her get her new “big girl job” as a Manufacturing Associate I ...
Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...
Training opportunities in North Carolina abound. From community college certificate programs to associate degrees and ...
The Accelerate NC Coalition is a statewide partnership dedicated to strengthening North Carolina’s life sciences ...
Young Women In Bio is an initiative of the RTP Women in Bio club. This initiative provides hands-on and virtual experiences ...
North Carolina is a leading life sciences hub with 840 companies employing 75,000 people. Statewide, life sciences companies ...
Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...
The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...
NCBiotech has launched enhanced resources for people exploring careers and training in the life sciences. Visit and share our new Careers and Training webpage at ncbiotech.org/careers-and-training.
URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity ...
The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...